Evidence map›Paper›PMID 39643433›Full record

SynthesisJournal of medical genetics2025

Tumour spectrum in

Olivia M Rostagni, Charlotte Lr Early, Mia B Hodges, Justice O Obasohan, Julie C Sapp, Alicia A Livinski, Leslie G Biesecker, Christopher A Ours

Abstract readSystematic Review
PubMed Full text at PMC Publisher
In one paragraph

Synthesis in Journal of medical genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Olivia M RostagniCenter for Precision Health Research, National Human Genome Research Institute, Bethesda, Maryland, USA.
Charlotte Lr EarlyCenter for Precision Health Research, National Human Genome Research Institute, Bethesda, Maryland, USA.
Mia B HodgesCenter for Precision Health Research, National Human Genome Research Institute, Bethesda, Maryland, USA.
Justice O ObasohanCenter for Precision Health Research, National Human Genome Research Institute, Bethesda, Maryland, USA.
Julie C SappCenter for Precision Health Research, National Human Genome Research Institute, Bethesda, Maryland, USA.
Alicia A LivinskiOffice of Research Services, Office of the Director, National Institutes of Health Library, Bethesda, Maryland, USA.
Leslie G BieseckerCenter for Precision Health Research, National Human Genome Research Institute, Bethesda, Maryland, USA.
Christopher A OursCenter for Precision Health Research, National Human Genome Research Institute, Bethesda, Maryland, USA chris.ours@nih.gov.ORCID 0000-0002-7831-1621

Funding

Rare & Mosaic Disorders - Clinical ResearchZIAHG200388 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI BIESECKER, LESLIE · 2013 to 2025
$17.3M
Genetic/Biochemical Approaches-Tyrosine Kinase FunctionZ01HG000123 · NHGRI · NATIONAL HUMAN GENOME RESEARCH INSTITUTE · PI SCHWARTZBERG, PAMELA · 1998 to 2008
$4.7M
Intramural NIH HHS Z01 HG000123Intramural NIH HHS ZIA HG200388
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

NeoplasmsProteus SyndromeProto-Oncogene Proteins c-aktAdolescentAdultChildFemaleGenetic Predisposition to DiseaseGenetic TestingHumansMaleMutationAKT1 protein, humanProto-Oncogene Proteins c-aktGenetic Predisposition to DiseaseGenetics, MedicalNeoplasms

Identifiers

PMID39643433
PMCPMC12107491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.